Paper36137125
Bibliometric analysis of hotspots and frontiers in cancer-related fatigue among ovarian cancer survivors.
Liu Y and 2 others. PLoS One, 2022. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Bibliometric analysis of hotspots and frontiers in cancer-related fatigue among ovarian cancer survivors. Papers, record 36137125. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36137125
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bibliometric analysis of hotspots and frontiers in cancer-related fatigue among ovarian cancer survivors.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cancer Survivors | Major topic |
| Ovarian Neoplasms | Major topic |
| Activities of Daily Living | |
| Bibliometrics | |
| Carcinoma, Ovarian Epithelial | |
| Cyclophosphamide | |
| Fatigue | |
| Female | |
| Humans | |
| Quality of Life | |
| Randomized Controlled Trials as Topic | |
| United States |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28301271 | Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980-2016). | Hum Vaccin Immunother | 2017 | https://conductscience.org/library/papers/28301271 | PubMed |
| 2 | 32920423 | Prevalence and risk factors of cancer-related fatigue: A systematic review and meta-analysis. | Int J Nurs Stud | 2020 | https://conductscience.org/library/papers/32920423 | PubMed |
| 3 | 34994826 | Global research trends in perioperative care for the elderly: a bibliometric and visualized study. | J Anesth | 2022 | https://conductscience.org/library/papers/34994826 | PubMed |
| 4 | 35055376 | Bibliometric Analysis of the Informal Caregiver's Scientific Production. | J Pers Med | 2022 | https://conductscience.org/library/papers/35055376 | PubMed |
| 5 | 25040957 | Fatigue and quality of life in women treated for various types of gynaecological cancers: a cross-sectional study. | J Clin Nurs | 2015 | https://conductscience.org/library/papers/25040957 | PubMed |
| 6 | 32893501 | Prevalence and severity of long-term physical, emotional, and cognitive fatigue across 15 different cancer entities. | Cancer Med | 2020 | https://conductscience.org/library/papers/32893501 | PubMed |
| 7 | 33013505 | An Extensive Knowledge Mapping Review of Measurement and Validity in Language Assessment and SLA Research. | Front Psychol | 2020 | https://conductscience.org/library/papers/33013505 | PubMed |
| 8 | 28223433 | Global Cancer in Women: Burden and Trends. | Cancer Epidemiol Biomarkers Prev | 2017 | https://conductscience.org/library/papers/28223433 | PubMed |
| 9 | 34616296 | Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French Patients. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34616296 | PubMed |
| 10 | 25037684 | A phase 1b, open-label study of trebananib in combination with paclitaxel and carboplatin in patients with ovarian cancer receiving interval or primary debulking surgery. | Eur J Cancer | 2014 | https://conductscience.org/library/papers/25037684 | PubMed |
| 11 | 28754483 | Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial. | Lancet Oncol | 2017 | https://conductscience.org/library/papers/28754483 | PubMed |
| 12 | 17573451 | Cancer-related fatigue: the scale of the problem. | Oncologist | 2007 | https://conductscience.org/library/papers/17573451 | PubMed |
| 13 | 16779135 | CiteSpace II: visualization and knowledge discovery in bibliographic databases. | AMIA Annu Symp Proc | 2005 | https://conductscience.org/library/papers/16779135 | PubMed |
| 14 | 33752410 | Adverse events of PARP inhibitors. | Ceska Gynekol | 2021 | https://conductscience.org/library/papers/33752410 | PubMed |
| 15 | 25113839 | Cancer-related fatigue--mechanisms, risk factors, and treatments. | Nat Rev Clin Oncol | 2014 | https://conductscience.org/library/papers/25113839 | PubMed |
| 16 | 26441008 | The effect of lifestyle interventions on the quality of life of gynaecological cancer survivors: A systematic review and meta-analysis. | Gynecol Oncol | 2015 | https://conductscience.org/library/papers/26441008 | PubMed |
| 17 | 35047380 | Mapping Intellectual Structures and Research Hotspots of Triple Negative Breast Cancer: A Bibliometric Analysis. | Front Oncol | 2021 | https://conductscience.org/library/papers/35047380 | PubMed |
| 18 | 2068837 | Fludarabine: a review. | DICP | 1991 | https://conductscience.org/library/papers/2068837 | PubMed |
| 19 | 34394765 | Applied Research in Quality of Life: A Computational Literature Review. | Appl Res Qual Life | 2022 | https://conductscience.org/library/papers/34394765 | PubMed |
| 20 | 34458138 | A 20-Year Research Trend Analysis of the Influence of Anesthesia on Tumor Prognosis Using Bibliometric Methods. | Front Oncol | 2021 | https://conductscience.org/library/papers/34458138 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42326332 | Development and validation of a machine learning-based risk prediction model for cancer-related fatigue in ovarian cancer patients. | Front Oncol | 2026 | https://conductscience.org/library/papers/42326332 | PubMed |
| 41732181 | Quantitative analysis of studies that use artificial intelligence on spinal diseases: A bibliometric analysis. | Digit Health | 2026 | https://conductscience.org/library/papers/41732181 | PubMed |
| 41417430 | Bibliometric analysis of global research on liquid biopsy for gastric cancer. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41417430 | PubMed |
| 39588489 | Research Hotspots and Frontiers of Patient Delay: A Bibliometric Analysis from 2000 to 2023. | J Multidiscip Healthc | 2024 | https://conductscience.org/library/papers/39588489 | PubMed |
| 38111527 | Application of medical imaging in ovarian cancer: a bibliometric analysis from 2000 to 2022. | Front Oncol | 2023 | https://conductscience.org/library/papers/38111527 | PubMed |
| 36969852 | The current trend of exosome in epithelial ovarian cancer studies: A bibliometric review. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36969852 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36137125
GET https://conductscience.org/api/papers/v1/36137125/references?page=2